Skip to main content

CHILD PEAK PRURITUS NRS EFFICACY RESULTS

In the treatment of children (6-11 years) with uncontrolled
moderate-to-severe atopic dermatitis

Itch relief in children

Clinically meaningful
itch relief IN AD-1652

6-11 YEARS

Itch reduction at Week 16 (secondary endpoint)1-3,a,b

aFull Analysis Set includes all subjects randomized.1

bIn the primary analyses of the efficacy endpoints, subjects who received rescue treatment or with missing data were considered nonresponders.1

cAt Day 1, subjects (baseline weight <30 kg) received 600 mg of DUPIXENT.1

dAt Day 1, subjects (baseline weight ≥30 kg) received 400 mg of DUPIXENT.1

Peak Pruritus NRS assesses the average itch intensity over the previous 24 hours4

It is a patient-reported measure that uses a 0- to 10-point scale, with which patients are asked:

“On a scale of 0 to 10, how would you rate your itch overall (on average) during the previous 24 hours?”

0 - NONE

1

2

3

4

5

6

7

8

9

10 - THE WORST
IMAGINABLE

A reduction of at least 4 points in Peak Pruritus NRS from baseline is a clinically meaningful change.1